ArticlePharmaceuticals (Basel, Switzerland)2025

Comparison Study of the Safety Profile of Olaparib Versus Niraparib: Analysis of Real-World Data from EudraVigilance.

Desirèe Speranza et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.